Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages

Archive ouverte

Descotes, Françoise | Dessen, Philippe | Bringuier, Pierre Paul | Decaussin, Myriam | Martin, Pierre Marie | Adams, Marjorie | Villers, Arnauld | Lechevallier, Eric | Rebillard, Xavier | Rodriguez-Lafrasse, Claire | Devonec, Marian | Paparel, Philippe | Perrin, Paul | Lazar, Vladimir | Ruffion, Alain

Edité par CCSD ; Wiley -

International audience. Objective To try and identify a molecular signature for pathological staging and/or grading. through microarray analysis. Patients and Methods We performed a prospective multicentre study between September 2007 and May 2008 that included 108 bladder tumours (45 pTa, 35 pT1 and 28>pT1). Microarray analysis was performed using Agilent Technologies Human Whole Genome 4 x 44K oligonucleotide microarrays (Agilent, Santa Clara, CA, USA). A 'dual colour' method was used vs a reference pool of tumours. From the lists of genes provided by the Biometric Research Branch class comparison analyses, we validated the microarray results of 38 selected differentially expressed genes using reverse transcriptase quantitative PCR in another bladder tumour cohort (n = 95). Results The cluster 'superficial vs invasive stage' correctly classified 92.9% of invasive stages and 66.3% of superficial stages. Among the superficial tumours, the cluster analysis showed that pT1b tumours were closer to invasive stages than pT1a tumours. We also found molecular differences between low and high grade superficial tumours, but these differences were less well defined than the difference observed for staging. Conclusions We confirmed that the histopathological classification into subgroups pTa, pT1a and pT1b can be translated into a molecular signature with a continuous progression of deregulation (overexpression or repression of these genes) from superficial (pTa) to more invasive (pT1a then b) stages.

Consulter en ligne

Suggestions

Du même auteur

Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience

Archive ouverte | Vlaeminck-Guillem, Virginie | CCSD

National audience. The poor specificity of diagnostic strategy for prostate cancer (digital rectal examination and seric PSA) induces both a great number of useless prostate biopsies and diagnosis of non evolutive c...

Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness.

Archive ouverte | Tallon, Lucile | CCSD

International audience. It has been suggested that urinary PCA3 and TMPRSS2: ERG fusion tests and serum PHI correlate to cancer aggressiveness-related pathological criteria at prostatectomy. To evaluate and compare ...

Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer

Archive ouverte | Boissier, Romain | CCSD

International audience

Chargement des enrichissements...